↓ Skip to main content

Dove Medical Press

S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway

Overview of attention for article published in Drug Design, Development and Therapy, October 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
11 Mendeley
Title
S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway
Published in
Drug Design, Development and Therapy, October 2020
DOI 10.2147/dddt.s258973
Pubmed ID
Authors

Guang Yang, Shui Sun, Jian Wang, Wei Li, Xianquan Wang, Lin Yuan, Siying Li

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 18%
Professor 1 9%
Unspecified 1 9%
Lecturer 1 9%
Student > Bachelor 1 9%
Other 0 0%
Unknown 5 45%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 9%
Unspecified 1 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Immunology and Microbiology 1 9%
Medicine and Dentistry 1 9%
Other 0 0%
Unknown 6 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2020.
All research outputs
#23,188,434
of 25,844,183 outputs
Outputs from Drug Design, Development and Therapy
#1,769
of 2,284 outputs
Outputs of similar age
#375,786
of 434,470 outputs
Outputs of similar age from Drug Design, Development and Therapy
#25
of 37 outputs
Altmetric has tracked 25,844,183 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,470 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.